# PENG vs L-ESPB With S-ESPB for Analgesia in Total Hip Arthroplasty

> **NCT07180979** · PHASE4 · RECRUITING · sponsor: **Poznan University of Medical Sciences** · enrollment: 90 (estimated)

## Conditions studied

- Hip Osteoarthritis
- Hip Arthropathy
- Hip Pain Chronic

## Interventions

- **DRUG:** Ropivacaine 0.5% Injectable Solution
- **DRUG:** Ropivacaine 0.2% Injectable Solution
- **DRUG:** Ropivacaine 0.2% Injectable Solution

## Key facts

- **NCT ID:** NCT07180979
- **Lead sponsor:** Poznan University of Medical Sciences
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2025-09-15
- **Primary completion:** 2026-09-30
- **Final completion:** 2026-11-30
- **Target enrollment:** 90 (ESTIMATED)
- **Last updated:** 2026-05-07


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07180979

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07180979, "PENG vs L-ESPB With S-ESPB for Analgesia in Total Hip Arthroplasty". Retrieved via AI Analytics 2026-07-04 from https://api.ai-analytics.org/clinical/NCT07180979. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*